Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children Article

Drilon, A., Laetsch, T. W., Kummar, S. et al. (2018). Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children . NEW ENGLAND JOURNAL OF MEDICINE, 378(8), 10.1056/NEJMoa1714448



Open Access Hot Paper ESI Most Cited Paper International Collaboration

cited authors

  • Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; Turpin, B.; Dowlati, A.; Brose, M. S.; Mascarenhas, L.; Federman, N.; Berlin, J.; El-Deiry, W. S.; Baik, C.; Deeken, J.; Boni, V.; Nagasubramanian, R.; Taylor, M.; Rudzinski, E. R.; Meric-Bernstam, F.; Sohal, D. P. S.; Ma, P. C.; Raez, L. E.; Hechtman, J. F.; Benayed, R.; Ladanyi, M.; Tuch, B. B.; Ebata, K.; Cruickshank, S.; Ku, N. C.; Cox, M. C.; Hawkins, D. S.; Hong, D. S.; Hyman, D. M.

fiu authors

publication date

  • February 2018

published in

category

Digital Object Identifier (DOI)

volume

  • 378

issue

  • 8

SDG 03: Good Health and Well-being

  • true

research area